Patrick Mayeux
Impact in
- Hematology top 0.2%
- Erythropoietin and Anemia Treatment
- Acute Myeloid Leukemia Research
- Iron Metabolism and Disorders
- Genetics top 0.5%
- Hemoglobinopathies and Related Disorders
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 16
- Hematology 71
- Erythropoietin and Anemia Treatment 27
- Acute Myeloid Leukemia Research 19
- Co-authors
- Catherine Lacombe (43 shared papers)Didier Bouscary (32 shared papers)Sylvie Gisselbrecht (33 shared papers)Stany Chrétien (27 shared papers)Nicole Casadevall (16 shared papers)Jérôme Tamburini (27 shared papers)Nicolas Chapuis (24 shared papers)O. Müller (15 shared papers)
- Journals
- Blood (51 papers)Journal of Biological Chemistry (15 papers)Haematologica (9 papers)Oncogene (5 papers)The EMBO Journal (3 papers)
- Partner nations
- FranceUnited StatesMorocco
In The Last Decade
Patrick Mayeux
155 papers receiving 8.2k citations
Patrick Mayeux's Hit Papers
Peers
Comparison fields: 5 of 125
- Hematology 3.0k
- Genetics 1.3k
- Immunology 1.7k
- Oncology 2.0k
- Molecular Biology 4.0k
Countries citing papers authored by Patrick Mayeux
This map shows the geographic impact of Patrick Mayeux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Mayeux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Mayeux more than expected).
Fields of papers citing papers by Patrick Mayeux
This network shows the impact of papers produced by Patrick Mayeux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Mayeux. The network helps show where Patrick Mayeux may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Mayeux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 158 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin Hit paper breakdown → | 2002 | 920 |
| 2 | 2002 | 263 | |
| 3 | 2009 | 245 | |
| 4 | 2007 | 209 | |
| 5 | 1996 | 195 | |
| 6 | 2012 | 173 | |
| 7 | 2016 | 172 | |
| 8 | 1998 | 168 | |
| 9 | Biology of erythropoietin. | 1998 | 165 |
| 10 | 1996 | 163 | |
| 11 | 2010 | 161 | |
| 12 | 2008 | 151 | |
| 13 | 2009 | 150 | |
| 14 | 2003 | 150 | |
| 15 | 1994 | 148 | |
| 16 | 2004 | 147 | |
| 17 | 2011 | 143 | |
| 18 | 1998 | 143 | |
| 19 | 2021 | 139 | |
| 20 | 2010 | 132 |
About Patrick Mayeux
Patrick Mayeux is a scholar working on Molecular Biology, Hematology, Physiology, Genetics and Oncology, having authored 158 papers that have together received 8.5k indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (60 papers), Erythropoietin and Anemia Treatment (27 papers), Hemoglobinopathies and Related Disorders (20 papers), Acute Myeloid Leukemia Research (19 papers), Cytokine Signaling Pathways and Interactions (16 papers), PI3K/AKT/mTOR signaling in cancer (16 papers), PARP inhibition in cancer therapy (15 papers) and Chronic Lymphocytic Leukemia Research (12 papers). The work is most often cited by research in Hematology (3.0k citations), Genetics (1.3k citations), Immunology (1.7k citations), Oncology (2.0k citations) and Molecular Biology (4.0k citations). Patrick Mayeux has collaborated with scholars based in France, United States and Morocco. Frequent co-authors include Catherine Lacombe, Didier Bouscary, Sylvie Gisselbrecht, Stany Chrétien, Nicole Casadevall, Jérôme Tamburini, Nicolas Chapuis, O. Müller, Frédèrique Verdier and François Dreyfus. Their work appears in journals such as Blood, Journal of Biological Chemistry, Haematologica, Oncogene and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.